After Surging Over 100% in a Year, Executives Reduce Holdings Amid Adaptive Biotech’s Strong Performance Mar 27, 2026 Life Science
Under the Spotlight of GLP-1, the Hidden Risks of Eli Lilly’s High Valuation Cannot Be Ignored Mar 26, 2026 Life Science
After Five Years of Sluggish Performance, Pfizer Finds Renewed Hope in High Dividends and Clinical Data Mar 25, 2026 Life Science
A Pullback or a Buying Opportunity? Analyzing Vertex Pharmaceuticals’ Growth Drivers for the Coming Year Mar 25, 2026 Life Science
Who Will Be the Next Oncology Giant? Axsome and Madrigal Could Overtake by 2026 Mar 25, 2026 Life Science
Tarsus Pharmaceuticals Chief Human Resources Officer Sells Shares, Transaction Highlights Company’s Commercial Momentum Mar 25, 2026 Life Science
Market Turmoil Got You on Edge? These Three Stocks Could Be Your Anchor Mar 23, 2026 Life Science, Technology
Hims & Hers Joins Hands with Former Rival, Hidden Concerns Loom Over the Weight Loss Drug Market Landscape Mar 18, 2026 Life Science
How is Pfizer Tackling the “Blockbuster Drug Drought” in the Post-Pandemic Era? Mar 17, 2026 Life Science
Novo Nordisk Partners with Hims & Hers: Can Turning a Foe into a Friend Reverse the Downturn? Mar 13, 2026 Life Science
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? Mar 12, 2026 Life Science
The Obesity Drug War Goes Oral: Why Eli Lilly’s Orforglipron Could Steal the Spotlight from Novo Mar 11, 2026 Life Science
This Stock Soared 1600% in a Year! Billionaire Cohen Had Already Positioned Himself Mar 11, 2026 Life Science
